D-0733-2026 Class II Ongoing
FDA drug recall D-0733-2026 was initiated by Aurobindo Pharma USA Inc on Jul 23, 2026 and is designated Class II. Reason for recall: shortfill; reports of empty capsules. The recall status is ongoing. Affected quantity: 6,408 bottles distributed to market.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 12, 2026
- Initiation Date
- Jul 23, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,408 bottles distributed to market
Product Description
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Reason for Recall
shortfill; reports of empty capsules.
Distribution Pattern
US Nationwide.
Code Information
Batch # DMC125018A, Exp Date: 07/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0733-2026
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026